“We’ve lost an opportunity to have direct government purchases of hundreds of thousands of doses of generic Truvada at a lower cost to dramatically lower HIV infections,” said Peter Staley… […]
In a rare move, the Dutch health ministry refused to provide coverage for a Gilead Sciences breast cancer treatment in a dispute over cost. […]
A deep dive by one pharma insider on the implications of the new drug pricing reform law. […]
In a victory for Gilead, Brazilian antitrust authorities dismissed a complaint alleging the company charged “abusive” prices for a hepatitis C treatment. […]
The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended consequences. […]
Copyright © 2023 Biotech Networks, LLC
